Modulation of nitric oxide production by tetracyclines and chemically modified tetracyclines. 1998

E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
Institute of General Pathology, University of Palermo, Italy.

Chemically modified tetracyclines (CMTs) dose-dependently decreased inducible nitric oxide synthase (iNOS) and, consequently, nitric oxide (NO) formation by the lipopolysaccharide (LPS)-stimulated J774 line. The inhibitory effect was due to a specific reduction in the iNOS protein content in the cells, as attested by Western blot analysis and by the inhibition of iNOS mRNA accumulation. Furthermore, CMTs cause a dose-dependent increase in cell death in the J774 line mediated by the NO-independent apoptotic mechanism.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013754 Tetracyclines Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
December 1996, Biochemical and biophysical research communications,
E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
March 1992, Current opinion in dentistry,
E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
June 1997, FEBS letters,
E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
October 2006, Journal of periodontal research,
E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
February 2001, Current medicinal chemistry,
E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
June 2017, Journal of clinical and diagnostic research : JCDR,
E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
May 2006, The Journal of surgical research,
E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
May 1997, Prostaglandins, leukotrienes, and essential fatty acids,
E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
September 2003, Shock (Augusta, Ga.),
E Cillari, and S Milano, and P D'Agostino, and G Di Bella, and M La Rosa, and C Barbera, and V Ferlazzo, and G Cammarata, and S Grimaudo, and M Tolomeo, and S Feo
June 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,
Copied contents to your clipboard!